Aspira Women's Health (AWH) Proxy filing summary

Executive summary

• Supplement corrects errors in previously reported beneficial ownership for two directors and updates executive officer changes as of April 2026.

• Brian Hungerford departed as Chief Financial Officer on April 26, 2026; Sandra Milligan left as Interim CEO in early 2025.

Voting matters and shareholder proposals

• Proxy voting instructions already submitted remain valid unless shareholders choose to change their vote.

Board of directors and corporate governance

• Updated table details beneficial ownership for all directors and executive officers as of April 20, 2026.

• All directors and executive officers as a group hold 9.4% of outstanding shares.